| 查看: 291 | 回复: 0 | |||
liushuai3788新虫 (初入文坛)
|
[交流]
【求助/交流】求关于rt-pcr的翻译
|
|
这一段是在看不懂了 只好来求助了 Serial 10-fold dilutions of GI and GII reference strains were amplified in triplicate and in parallel.The dilution curveswere linear over 5 and 6 orders of magnitude for the GI and GII real time assays,respectively.The slopes and the regression coefficients indicated good amplification efficiency.Fig.1 shows that the S35 strain titer was 10-fold higher than the Norwalk strain titer,but both were detected at 1 RT-PCR unit by the real-time RT-PCR assays with a mean Ct value of 42.4 and 40.1,respectively.They were both negative at the 0.1 RT-PCR U.The reproducibility was evaluated by testing serial dilutions of the positive control on ten separate runs.For the Norwalk strain,the variability was 2.8%for detection of 10 RT-PCR U(Ct values from 37.62 to 38.71)and for the GII S35 strain,the variability was 2.4%for detection of 10 RT-PCR U(Ct values from 38.84 to 39.79). |
回复此楼» 猜你喜欢
Dordaviprone（ONC201）：小分子药物在中线胶质瘤中的应用
已经有0人回复
-
依喜替康：新型喜树碱衍生物的研究进展
已经有1人回复
-
化学工程及工业化学论文润色/翻译怎么收费?
已经有185人回复
-
膀胱癌靶向治疗新选择：厄达替尼作用机制与耐药研究进展
已经有0人回复
-
从水母到实验室：腔肠素的发现历程与生物发光奥秘
已经有1人回复
-
线粒体氧化磷酸化的新靶点：S-Gboxin的发现与研究进展
已经有0人回复
-
PROTAC药物开发选择VHL配体：MDK-7526以87%出口向量占有率成首选
已经有0人回复
-
MCC950：NLRP3炎症小体特异性抑制剂的科研应用与前景
已经有0人回复
-
康替唑胺研发17年：如何解决多重耐药菌感染难题
已经有0人回复
-
伊曲莫德（Etrasimod）从“肠道免疫失控”到精准靶向干预
已经有0人回复